Factor Xa inhibitors in patients with continuous-flow left ventricular assist devices
ConclusionsFactor Xa inhibitors may be viable treatment options for CF-LVAD patients for whom warfarin therapy has failed. Large prospective studies are necessary to confirm these results.
Source: General Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research
More News: Atrial Fibrillation | Bleeding | Cardiology | Cardiomyopathy | Cardiovascular | Cardiovascular & Thoracic Surgery | Coumadin | Diabetes | Diabetes Mellitus | Endocrinology | Gastroenterology | Heart | Heart Attack | Hemorrhagic Stroke | Hypertension | Ischemic Stroke | Stroke | Study | Thrombosis | Warfarin